UPCI / UPMC CC Press Releases

Pitt Appoints New Division Chief of Hematology/Oncology

Pittsburgh, PA September 22, 2010 – Edward Chu, M.D., an internationally renowned expert in the biology and treatment of colorectal cancer, has been named chief of the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine and deputy director of the University of Pittsburgh Cancer Institute (UPCI).

"We are thrilled to have such an accomplished cancer investigator join us," said Nancy E. Davidson, M.D., director of UPCI and UPMC Cancer Centers. "Under Dr. Chu's leadership, we anticipate the Division of Hematology/Oncology, as well as UPCI, will play an even greater national and international leadership role in cancer research and cancer treatment. Ed is the consummate clinician-scientist, constantly striving to improve our understanding of how cancer drugs work so that he can improve care for the patient."

Before coming to UPCI, Dr. Chu served as a professor of medicine and pharmacology at Yale University School of Medicine, chief of the Section of Medical Oncology and Deputy Director of the Yale Cancer Center.

An accomplished cancer researcher, Dr. Chu is well-recognized for his contributions in understanding the action of antimetabolites in cancer therapy. His findings have been published in more than 160 publications, and his work has been funded through the National Cancer Institute (NCI) and the Veterans Administration Merit Program. He has served as a member of numerous editorial boards and been an active member of the peer review process, serving as a member and chair of the National Institutes of Health/NCI Experimental Therapuetics 1 Study Section.

Dr. Chu received a B.A., an M.M.S. in pharmacology and an M.D. from Brown University. He then completed an internal medicine residency and served as chief medical resident at the Roger Williams Hospital of Brown University. In 1987, he began training in medical oncology at the NCI, where he extended his interest in cancer pharmacology and gastrointestinal oncology, and he served as a tenured senior clinical investigator in the NCI-Navy Medical Oncology Branch at the NCI in Maryland.

"I am extremely excited and honored to take on my new roles at UPCI and the University of Pittsburgh," said Dr. Chu. "As the leading institution in western Pennsylvania for the delivery of cancer care, the conduct of cancer research and the education of future generations of oncologists, UPCI plays a critically important role in the fight against cancer. I look forward to working closely with Dr. Davidson and her leadership team at UPCI as we work to improve the lives of our cancer patients."

# # #

About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1997 and now ranks fifth in the nation, according to NIH data for 2008 (the most recent year for which the data are final).

Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see

About the University of Pittsburgh Cancer Institute (UPCI)
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. UPCI investigators are world-renowned for their work in clinical and basic cancer research.